Patient-Reported Physical Function Measures in Cancer Clinical Trials
Open Access
- 1 January 2017
- journal article
- review article
- Published by Oxford University Press (OUP) in Epidemiologic Reviews
- Vol. 39 (1) , 59-70
Abstract
Patient-reported outcomes (PROs) are increasingly used to monitor treatment-related symptoms and physical function decrements in cancer clinical trials. As more patients enter survivorship, it is important to capture PRO physical function throughout trials to help restore pretreatment levels of function. We completed a systematic review of PRO physical function measures used in cancer clinical trials and evaluated their psychometric properties on the basis of guidelines from the US Food and Drug Administration. Five databases were searched through October 2015: PubMed/MEDLINE, EMBASE, CINAHL (Cumulative Index of Nursing and Allied Health Literature), Health and Psychosocial Instruments, and Cochrane. From an initial total of 10,233 articles, we identified 108 trials that captured PRO physical function. Within these trials, approximately 67% used the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire and 25% used the Medical Outcomes Study Short Form 36. Both the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire and Medical Outcomes Study Short Form 36 instruments generically satisfy most Food and Drug Administration requirements, although neither sought direct patient input as part of item development. The newer Patient-Reported Outcomes Measurement Information System physical function short form may be a brief, viable alternative. Clinicians should carefully consider the psychometric properties of these measures when incorporating PRO instrumentation into clinical trial design to provide a more comprehensive understanding of patient function.Keywords
Funding Information
- National Institutes of Health research training (T32 CA009461-25)
- National Institutes of Health (P30 CA08748-50)
This publication has 137 references indexed in Scilit:
- Reliability of adverse symptom event reporting by cliniciansQuality of Life Research, 2011
- Minimally important differences were estimated for six Patient-Reported Outcomes Measurement Information System-Cancer scales in advanced-stage cancer patientsJournal of Clinical Epidemiology, 2011
- Poor physical health predicts time to additional breast cancer events and mortality in breast cancer survivorsPsycho-Oncology, 2011
- The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008Journal of Clinical Epidemiology, 2010
- Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trialThe Lancet Oncology, 2010
- The Missing Voice of Patients in Drug-Safety ReportingNew England Journal of Medicine, 2010
- Impact of a walking intervention on cardiorespiratory fitness, self‐reported physical function, and pain in patients undergoing treatment for solid tumorsCancer, 2009
- Development of a methodological PubMed search filter for finding studies on measurement properties of measurement instrumentsQuality of Life Research, 2009
- Validation of Single-Item Linear Analog Scale Assessment of Quality of Life in Neuro-Oncology PatientsJournal of Pain and Symptom Management, 2007
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI: Journal of the National Cancer Institute, 1993